PERA: Where Patent Law and Healthcare Issues Collide

U.S. Supreme Court opinions in Mayo Collaborative Services v. Prometheus Laboratories, Inc., Association for Molecular Pathology v. Myriad Genetics, Inc., and Alice Corporation Pty. Ltd. V. CLS Bank International et al., produced significant challenges to and unpredictability in obtaining and enforcing patent protection in areas including precision medicine, diagnostics, AI, and pharmaceutical treatments. The Patent Eligibility Restoration Act of 2025 (PERA), S. 1546 and the identical H.R. 3152, seek to address these challenges by rewriting 35 U.S.C. § 101 to eliminate all of these “judicial exceptions to patent eligibility.”

The Intangible Investor: What You Can See Everything Reveals About Invention

You Can See Everything is a thought-provoking amalgam of fact, flare and creative personality profiling inventor Elizabeth Holmes and her partner, Billy Evans, as she prepares for an 11-year prison sentence for defrauding high-profile investors. While her name is associated with more than 150 patents, it is unclear exactly what she invented and the nature of the value it has generated.  

Enforcing IP Rights in Brazil: Why Litigation Is Not Always the First Step

For foreign companies holding trademarks, patents, industrial designs, or other intellectual property assets in Brazil, detecting an infringement can trigger an almost automatic reaction: filing a lawsuit. Although resorting to the courts is an important tool for protecting intellectual property rights, it does not necessarily need to be the first step.

AI and Drug Patents: Are Super-Fast Followers a Threat to Pharmaceutical Innovation? | IPWatchdog Unleashed

This week on IPWatchdog Unleashed, I spoke with Emily Johnson, Nicholas Lanzatella, Kwame Mensah, and Corey Salsberg. This conversation took place on November 9, 2026, at IPWatchdog Studios at the fifth annual Life Sciences Masters™ conference. We examine how artificial intelligence is changing life sciences research and patent strategy. Our focus was on the emergence of super-fast followers, who are competitors positioned to quickly analyze published inventions and rapidly pursue related candidates and patent filings. For an industry built on expensive, uncertain research, the implications reach well beyond faster drafting or more efficient discovery. At stake is the balance between accelerating the development of new medicines and preserving the economic incentives that make pioneering discoveries possible in the first place.

CAFC Vacates Finding of Non-Infringement Due to District Court’s Failure to Resolve Claim Construction Dispute

The U.S. Court of Appeals for the Federal Circuit (CAFC) on Wednesday vacated a judgment of no infringement and affirmed a validity finding for patent owner Edge Systems LLC. The nonprecedential opinion was authored by Judge Prost and joined by Judges Hughes and Cunningham.

AI-assisted SEP Prosecution to Build Portfolios for Licensing, Sale, or Enforcement

Standard-essential patents (SEPs) are among the most valuable assets in today’s technology economy. They form the foundation of licensing programs, determine competitive positioning, and increasingly become the center of high-stakes litigation across multiple jurisdictions. Yet one reality remains unchanged: many SEPs that initially appear to be strong eventually fail when scrutinized in court.

Federal Circuit Affirms Indefiniteness of Breathable Membrane Patent Claims Over Unspecified Measurement Method

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Tuesday in Cocona, Inc. v. VF Outdoor, LLC, affirming a judgment of the U.S. District Court for the District of Colorado that held three claims of a waterproof, breathable membrane patent invalid as indefinite. Circuit Judge Stark wrote for the court, joined by Circuit Judges Lourie and Stoll, and agreed with the district court that the asserted claims recited a numerical range for moisture vapor transmission rate (MVTR) without specifying a method for measuring it.

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates